The Neuron-specific IIS/FOXO Transcriptome in Aged Animals Reveals Regulatory Mechanisms of Neuronal and Cognitive Aging

Yifei Weng,Shiyi Zhou,Katherine Morillo,Rachel Kaletsky,Sarah Lin,Coleen Murphy
DOI: https://doi.org/10.1101/2023.07.28.550894
2024-06-18
Abstract:Cognitive decline is a significant health concern in our aging society. Here, we used the model organism C. elegans to investigate the impact of the IIS/FOXO pathway on age-related cognitive decline. The daf-2 Insulin/IGF-1 receptor mutant exhibits a significant extension of learning and memory span with age compared to wild-type worms, an effect that is dependent on the DAF-16 transcription factor. To identify possible mechanisms by which aging daf-2 mutants maintain learning and memory with age while wild-type worms lose neuronal function, we carried out neuron-specific transcriptomic analysis in aged animals. We observed downregulation of neuronal genes and upregulation of transcriptional regulation genes in aging wild-type neurons. By contrast, IIS/FOXO pathway mutants exhibit distinct neuronal transcriptomic alterations in response to cognitive aging, including upregulation of stress response genes and downregulation of specific insulin signaling genes. We tested the roles of significantly transcriptionally-changed genes in regulating cognitive functions, identifying novel regulators of learning and memory. In addition to other mechanistic insights, comparison of the aged vs young daf-2 neuronal transcriptome revealed that a new set of potentially neuroprotective genes is upregulated; instead of simply mimicking a young state, daf-2 may enhance neuronal resilience to accumulation of harm and take a more active approach to combat aging. These findings suggest a potential mechanism for regulating cognitive function with age and offer insights into novel therapeutic targets for age-related cognitive decline.
Neuroscience
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore how the insulin/IGF - 1 signaling pathway (IIS/FOXO) affects the decline of cognitive function during the aging process. Specifically, the researchers used the nematode (*C. elegans*) as a model organism. By analyzing the neuron - specific transcriptome changes of daf - 2 mutants (an insulin/IGF - 1 receptor mutant) and wild - type nematodes during the aging process, they explored why daf - 2 mutants can maintain better learning and memory abilities while wild - type nematodes lose these functions as they age. The main objectives of the study include: 1. **Identify the molecular mechanisms that cause wild - type nematodes to lose their learning and memory abilities as they age**: By comparing the neuronal transcriptome differences between young (1 - day - old adult stage) and old (8 - day - old adult stage) wild - type nematodes, the researchers hope to find gene expression changes related to the decline of cognitive function. 2. **Explore how daf - 2 mutants maintain their neuronal functions**: By comparing the neuronal transcriptome differences among daf - 2 mutants, wild - type nematodes, and daf - 16;daf - 2 double mutants (daf - 16 is a FOXO transcription factor, and the function of daf - 2 depends on it) during the aging process, the researchers aim to discover the gene expression changes unique to daf - 2 mutants. These changes may contribute to their maintaining higher cognitive functions. 3. **Identify new neuroprotective genes**: The researchers hope to find genes that are specifically up - regulated in daf - 2 mutants through the above - mentioned comparisons. These genes may have a neuroprotective effect, thus helping to maintain neuronal health and resist environmental damage. In summary, the core problem of this paper is to reveal the influence mechanism of the IIS/FOXO signaling pathway on cognitive function during the aging process through in - depth transcriptomics analysis, and how daf - 2 mutants delay cognitive decline through specific gene expression changes. This not only helps to understand neurodegenerative changes during the aging process but may also provide new clues for the development of treatment strategies for age - related cognitive disorders.